{
  "id": "cluster_45_doc2",
  "content": "University Health providers identified a pattern of monoclonal antibody pre-authorizations taking 8-12 business days within endovascular therapy networks during March-May 2024, against plan SLA of 72 hours. Dr. Martinez (PROVIDER #338950) flagged resolution delays impacting congenital heart patients participating in longitudinal LIFESTUDY-45. Update: Non-stationary monitoring devices approved for home use effective June 1, requiring modified billing codes under policy document HB-2245-UC.",
  "metadata": {
    "format": "provider_report"
  }
}